Alzheimer disease F020

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/b/alzheimer-type-dementia-f020-g30

Last amended

Factors in CCPS as at 16 September 2011 (F020)

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020

Last amended

A moderate to severe cerebral trauma

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/moderate-severe-cerebral-trauma

Last amended

Cigar smoking

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/cigar-smoking

Last amended

Cigarette smoking

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/cigarette-smoking

Last amended

Diabetes Mellitus

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/diabetes-mellitus

Last amended

Dyslipidaemia

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/dyslipidaemia

Last amended

Electromagnetic field exposure

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/electromagnetic-field-exposure

Last amended

Hyperhomocysteinaemia

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/hyperhomocysteinaemia

Last amended

Hypertension

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/hypertension

Last amended

Inability to obtain appropriate clinical management for Alzheimer-type dementia

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/inability-obtain-appropriate-clinical-management-alzheimer-type-dementia

Last amended

Major depressive episodes

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/major-depressive-episodes

Last amended

Obesity

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/obesity

Last amended

Pipe smoking

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/pipe-smoking

Last amended

Smoking tobacco products - material contribution

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/smoking-tobacco-products-material-contribution

Last amended

Thyroid Disorder

Current RMA Instruments
Reasonable Hypothesis SOP
33 of 2019
Balance of Probabilities SOP
34 of 2019
Changes from previous Instruments

ICD Coding
  • ICD-9-CM Codes: 331.0
  • ICD-10-AM Codes: G30
Brief description

The SOP covers both dementia (major neurocognitive disorder) and also mild neurocognitive disorder from Alzheimer disease.  Alzheimer disease is the commonest form of dementia, and affects approximately 1 in 9 people aged over 65.  The condition is unlikely to be present before age 60.

Confirming the diagnosis

The diagnosis is made clinically, based on history and examination, including cognitive testing.  Neuroimaging and other testing may be performed.  Such tests are not diagnostic but can rule out other causes or support an Alzheimer diagnosis.  Characteristic features of Alzheimer disease include memory impairment, particularly for recent events, decline in executive function, decline in judgment/problem solving, and visuospatial impairment.

The condition can be difficult to diagnose clinically and to distinguish from vascular dementia, dementia with Lewy bodies or other neurodegenerative dementias.  The diagnosis can also be confirmed pathologically, at autopsy.

The relevant medical specialist is a neurologist or geriatrician.

Additional diagnoses covered by these SOPs
  • Alzheimer’s disease
  • Alzheimer's dementia
Conditions not covered by these SOPs
  • Dementia with Lewy bodies* - neurocognitive disorder with Lewy bodies SOP
  • Frontotemporal dementia#
  • Multi-infarct dementia* (vascular dementia SOP)
  • Preclinical Alzheimer disease (asymptomatic, cognitively normal) - not a disease or injury
  • Vascular dementia*
  • Any other identifiable cause of dementia, ICD code as appropriate

* another SOP applies

# non-SOP condition

Clinical onset

Clinical onset will be when symptoms and findings on clinical examination were first sufficent to allow an appropriate medical practitioner to say the condition was present.  Onset is typically after age 65.

Clinical worsening

Alzheimer dementia inevitably progresses in all patients.  Mild congnitive imapirment does not always progress.  For both forms, there is no treatment available that modifies the course of the condition.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/b/alzheimer-type-dementia-f020/factors-ccps-16-september-2011-f020/thyroid-disorder

Last amended